News Sentiment

IKT sentiment intelligence

Inhibikase Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 40 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.11 Week of 17 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 31

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+3.4% over one week, +15.3% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Inhibikase Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction 3.4% Price confirming higher
Trend fit Trend active 15.3% over four weeks
Fair value 14.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 26
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 31
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 11
Market source 6
MarketBeat 5
TradingView 4
simplywall.st 3
Moomoo 2
GlobeNewswire 2
MLQ.ai 1

Event Lens

What the news is about

Classified themes
Market update 19
Earnings 11
Analyst action 4
Deals and strategy 3
Balance sheet 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-40 of 40